Bulletin
Investor Alert

New York Markets Close in:

Repligen Corp.

NAS: RGEN

GO
/marketstate/country/us

Market open

/zigman2/quotes/210324360/composite

$

206.19

Change

-3.73 -1.78%

Volume

Volume 87,627

Jul 26, 2021, 12:12 p.m.

Real time quotes

/zigman2/quotes/210324360/composite

Previous close

$ 209.92

$ 206.19

Change

-3.73 -1.78%

Day low

Day high

$205.02

$209.77

Open
Open: 209.22

52 week low

52 week high

$135.23

$228.84

Open

Market cap

$11.53B

Average volume

390,185

P/E ratio

142.32

Rev. per Employee

$324,699

EPS

1.45

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/rgen

MarketWatch News on RGEN

  1. Repligen started at overweight with $241 stock price target at KeyBanc Capital

    8:03 a.m. Nov. 10, 2020

    - Tomi Kilgore

  2. Small-Cap ‘Darlings’ Are Perking Up in 2020

    11:47 a.m. Jan. 21, 2020

    - Barron's Online

  3. These 6 stocks in the S&P 1500 have more than doubled in 12 months

    7:28 a.m. July 13, 2019

    - Philip van Doorn

  4. Repligen started at overweight with $42 stock price target at J.P. Morgan

    8:28 a.m. Dec. 5, 2017

    - Tomi Kilgore

  5. Repligen stock fair value estimate raised to $47 from $42 at Janney

    11:26 a.m. June 23, 2017

    - Tomi Kilgore

  6. Repligen agrees to buy Spectrum in a cash-and-stock deal valued at $359 mln

    7:01 a.m. June 23, 2017

    - Tomi Kilgore

  7. Repligen's stock halted for news pending

    6:58 a.m. June 23, 2017

    - Tomi Kilgore

  8. Repligen's stock was inactive premarket prior to trading halt

    6:59 a.m. June 23, 2017

    - Tomi Kilgore

  9. Investing From the Ground Up

    12:13 a.m. Sept. 15, 2016

    - Barron's Online

  10. Why Danaher’s Purchase of Pall Means More M&A is on the Way

    11:39 a.m. May 13, 2015

    - Barrons Blogs

  11. Bull trend absorbs soft second-quarter start

    10:41 a.m. April 6, 2015

    - Michael Ashbaugh

  12. These are the most profitable Nasdaq biotech companies

    12:36 p.m. March 2, 2015

    - Philip van Doorn

  13. Here are the best-performing stocks so far in 2015

    12:47 p.m. Jan. 9, 2015

    - Philip van Doorn

  14. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/rgen

Other News on RGEN

  1. Notable earnings before Tuesday's open

    10:08 a.m. Today

    - Seeking Alpha

  2. 3 Healthcare Stocks to Buy and Hold for the Next 10 Years

    6:15 a.m. July 22, 2021

    - Motley Fool

  3. Bet on Rising P/E Investing With These Top 5 Stocks

    5:28 a.m. July 5, 2021

    - Zacks.com

  4. Arcutis (ARQT) Terminates Study of Drug to Treat Vitiligo

    11:01 a.m. July 2, 2021

    - Zacks.com

  5. Horizon (HZNP) Begins Phase II Study for Lupus Candidate

    11:08 a.m. June 30, 2021

    - Zacks.com

  6. Loading more headlines...
/news/pressrelease/company/us/rgen

Press Releases on RGEN

  1. Immunoassay Kits Market Report 2020, Trends and Forecast till 2027

    2:30 a.m. Today

    - Comserve

  2. Chromatography Resin Market Trends and Forecast 2028

    5:14 a.m. July 23, 2021

    - Market Insight Reports

  3. Loading more headlines...

Rates »

Link to MarketWatch's Slice.